Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.

Cosgrove CM, Tritchler DL, Cohn DE, Mutch DG, Rush CM, Lankes HA, Creasman WT, Miller DS, Ramirez NC, Geller MA, Powell MA, Backes FJ, Landrum LM, Timmers C, Suarez AA, Zaino RJ, Pearl ML, DiSilvestro PA, Lele SB, Goodfellow PJ.

Gynecol Oncol. 2018 Jan;148(1):174-180. doi: 10.1016/j.ygyno.2017.10.037. Epub 2017 Nov 11.

2.

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.

McMeekin DS, Tritchler DL, Cohn DE, Mutch DG, Lankes HA, Geller MA, Powell MA, Backes FJ, Landrum LM, Zaino R, Broaddus RD, Ramirez N, Gao F, Ali S, Darcy KM, Pearl ML, DiSilvestro PA, Lele SB, Goodfellow PJ.

J Clin Oncol. 2016 Sep 1;34(25):3062-8. doi: 10.1200/JCO.2016.67.8722. Epub 2016 Jun 20.

3.

Identification of consistent functional genetic modules.

Miecznikowski JC, Gaile DP, Chen X, Tritchler DL.

Stat Appl Genet Mol Biol. 2016 Mar;15(1):1-18. doi: 10.1515/sagmb-2015-0026.

PMID:
26756095
4.

Information metrics in genetic epidemiology.

Tritchler DL, Sucheston L, Chanda P, Ramanathan M.

Stat Appl Genet Mol Biol. 2011;10:Article 12.

5.

Mammographic densities and breast cancer risk.

Boyd NF, Lockwood GA, Martin LJ, Knight JA, Byng JW, Yaffe MJ, Tritchler DL.

Breast Dis. 1998 Aug;10(3-4):113-26.

PMID:
15687568
6.

Mammographic density as a marker of susceptibility to breast cancer: a hypothesis.

Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL.

IARC Sci Publ. 2001;154:163-9. Review.

PMID:
11220655
7.

Breast cancer risk and measured mammographic density.

Yaffe MJ, Boyd NF, Byng JW, Jong RA, Fishell E, Lockwood GA, Little LE, Tritchler DL.

Eur J Cancer Prev. 1998 Feb;7 Suppl 1:S47-55.

PMID:
10866036
8.

Mammographic densities and risk of breast cancer among subjects with a family history of this disease.

Boyd NF, Lockwood GA, Martin LJ, Knight JA, Jong RA, Fishell E, Byng JW, Yaffe MJ, Tritchler DL.

J Natl Cancer Inst. 1999 Aug 18;91(16):1404-8.

PMID:
10451446
9.

Macronutrient intake and change in mammographic density at menopause: results from a randomized trial.

Knight JA, Martin LJ, Greenberg CV, Lockwood GA, Byng JW, Yaffe MJ, Tritchler DL, Boyd NF.

Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):123-8.

10.

Mammographic densities and breast cancer risk.

Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ.

Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1133-44. Review.

11.

Analysis of mammographic density and breast cancer risk from digitized mammograms.

Byng JW, Yaffe MJ, Jong RA, Shumak RS, Lockwood GA, Tritchler DL, Boyd NF.

Radiographics. 1998 Nov-Dec;18(6):1587-98. Review.

PMID:
9821201
12.

The relationship of anthropometric measures to radiological features of the breast in premenopausal women.

Boyd NF, Lockwood GA, Byng JW, Little LE, Yaffe MJ, Tritchler DL.

Br J Cancer. 1998 Nov;78(9):1233-8.

13.

Automated analysis of mammographic densities and breast carcinoma risk.

Byng JW, Yaffe MJ, Lockwood GA, Little LE, Tritchler DL, Boyd NF.

Cancer. 1997 Jul 1;80(1):66-74.

PMID:
9210710
15.

Comparison of energy intakes determined by food records and doubly labeled water in women participating in a dietary-intervention trial.

Martin LJ, Su W, Jones PJ, Lockwood GA, Tritchler DL, Boyd NF.

Am J Clin Nutr. 1996 Apr;63(4):483-90.

PMID:
8599310
16.

Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study.

Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ.

J Natl Cancer Inst. 1995 May 3;87(9):670-5.

PMID:
7752271
17.

High-dose cytosine arabinoside remission induction for acute myelogenous leukemia: comparison of two regimens of remission maintenance.

Curtis JE, Messner HA, Minden MD, Lipton JH, Lockwood GA, Tritchler DL, McCulloch EA.

Leukemia. 1992 Nov;6(11):1192-8.

PMID:
1434804
18.

Benign and malignant breast disease: the relationship between women's health status and health values.

Llewellyn-Thomas HA, Sutherland HJ, Tritchler DL, Lockwood GA, Till JE, Ciampi A, Scott JF, Lickley LA, Fish EB.

Med Decis Making. 1991 Jul-Sep;11(3):180-8.

PMID:
1881274
19.

Communicating probabilistic information to cancer patients: is there 'noise' on the line?

Sutherland HJ, Lockwood GA, Tritchler DL, Sem F, Brooks L, Till JE.

Soc Sci Med. 1991;32(6):725-31.

PMID:
2035049
20.

Use of written cases to study factors associated with regional variations in referral rates.

Langley GR, Tritchler DL, Llewellyn-Thomas HA, Till JE.

J Clin Epidemiol. 1991;44(4-5):391-402.

PMID:
2010782
21.

Whose utilities for decision analysis?

Boyd NF, Sutherland HJ, Heasman KZ, Tritchler DL, Cummings BJ.

Med Decis Making. 1990 Jan-Mar;10(1):58-67.

PMID:
2182963
22.

Cancer patients: their desire for information and participation in treatment decisions.

Sutherland HJ, Llewellyn-Thomas HA, Lockwood GA, Tritchler DL, Till JE.

J R Soc Med. 1989 May;82(5):260-3.

23.

Measuring satisfaction with health care: a comparison of single with paired rating strategies.

Sutherland HJ, Lockwood GA, Minkin S, Tritchler DL, Till JE, Llewellyn-Thomas HA.

Soc Sci Med. 1989;28(1):53-8.

PMID:
2928814
24.

Response to 5-azacytidine of leukemic blast cells in suspension: a biological parameter associated with response to chemotherapy.

Wang C, Curtis JE, Senn JS, Tritchler DL, McCulloch EA.

Leukemia. 1987 Nov;1(11):753-6.

PMID:
2446086
25.

The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia.

Nara N, Curtis JE, Senn JS, Tritchler DL, McCulloch EA.

Blood. 1986 Mar;67(3):762-9.

26.

Eliciting preferences for alternative cancer drug treatments. The influence of framing, medium, and rater variables.

O'Connor AM, Boyd NF, Tritchler DL, Kriukov Y, Sutherland H, Till JE.

Med Decis Making. 1985 Winter;5(4):453-63.

PMID:
3842425

Supplemental Content

Loading ...
Support Center